IQGEN Holdings LLC has marked the final close of its maiden venture capital fund at $25 million. The Vantage fund aims to invest in technology-driven healthcare companies in India and other Asian countries.

With Vantage, IQGEN aims to establish itself as the one-stop shop for healthcare in India and Asia. The fund has plans to invest in companies in collaboration with governments and key organisations that it has connections to in the region.

Within the healthcare segment, Vantage will focus on investing in telemedicine, data analytics in diagnostics, artificial intelligence in medicine, robotics in surgery, wellness and health insurance.

The fund will primarily participate in pre-Series A and Series A rounds of companies. It aims to invest $1-5 million each in its target companies.